TITLE

Improved prediction of HIV-1 protease-inhibitor binding energies by molecular dynamics simulations

AUTHOR(S)
Jenwitheesuk, Ekachai; Samudrala, Ram
PUB. DATE
January 2003
SOURCE
BMC Structural Biology;2003, Vol. 3, p2
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: The accurate prediction of enzyme-substrate interaction energies is one of the major challenges in computational biology. This study describes the improvement of protein-ligand binding energy prediction by incorporating protein flexibility through the use of molecular dynamics (MD) simulations. Results: Docking experiments were undertaken using the program AutoDock for twenty-five HIV-1 protease-inhibitor complexes determined by x-ray crystallography. Protein-rigid docking without any dynamics produced a low correlation of 0.38 between the experimental and calculated binding energies. Correlations improved significantly for all time scales of MD simulations of the receptor-ligand complex. The highest correlation coefficient of 0.87 between the experimental and calculated energies was obtained after 0.1 picoseconds of dynamics simulation. Conclusion: Our results indicate that relaxation of protein complexes by MD simulation is useful and necessary to obtain binding energies that are representative of the experimentally determined values.
ACCESSION #
29323537

 

Related Articles

  • Binding of novel fullerene inhibitors to HIV-1 protease: insight through molecular dynamics and molecular mechanics Poisson-Boltzmann surface area calculations. Tzoupis, Haralambos; Leonis, Georgios; Durdagi, Serdar; Mouchlis, Varnavas; Mavromoustakos, Thomas; Papadopoulos, Manthos // Journal of Computer-Aided Molecular Design;Oct2011, Vol. 25 Issue 10, p959 

    The objectives of this study include the design of a series of novel fullerene-based inhibitors for HIV-1 protease (HIV-1 PR), by employing two strategies that can also be applied to the design of inhibitors for any other target. Additionally, the interactions which contribute to the observed...

  • Enhancing the accuracy of virtual screening: molecular dynamics with quantum-refined force fields. Curioni, Alessandro; Mordasini, Tiziana; Andreoni, Wanda // Journal of Computer-Aided Molecular Design;Dec2004, Vol. 18 Issue 12, p773 

    A methodology aimed at improving the accuracy of current docking�scoring procedures is proposed, and validated through detailed tests of its performance in predicting the activity of HIV-1 protease inhibitors. This methodology is based on molecular dynamics simulations using a force field...

  • Binding energy calculations for hevein-carbohydrate interactions using expanded ensemble molecular dynamics simulations. Koppisetty, Chaitanya; Frank, Martin; Lyubartsev, Alexander; Nyholm, Per-Georg // Journal of Computer-Aided Molecular Design;Jan2015, Vol. 29 Issue 1, p13 

    Accurate estimation of protein-carbohydrate binding energies using computational methods is a challenging task. Here we report the use of expanded ensemble molecular dynamics (EEMD) simulation with double decoupling for estimation of binding energies of hevein, a plant lectin with its...

  • Coarse-grained molecular dynamics of ligands binding into protein: The case of HIV-1 protease inhibitors. Dechang Li; Liu, Ming S.; Baohua Ji; Kehchih Hwang; Yonggang Huang // Journal of Chemical Physics;6/7/2009, Vol. 130 Issue 21, p215102 

    Binding dynamics and pathways of ligands or inhibitors to target proteins are challenging both experimental and theoretical biologists. A dynamics understanding of inhibitors interacting with protein is essential for the design of novel potent drugs. In this work we applied a coarse-grained...

  • Development of Anti-HIV Activity Models of Lysine Sulfonamide Analogs: A QSAR Perspective. Muthukumaran, Rajagopalan; Sangeetha, Balasubramanian; Amutha, Ramaswamy; Mathur, Premendu P. // Current Computer-Aided Drug Design;Mar2012, Vol. 8 Issue 1, p70 

    Lysine sulfonamide and its structural analogs, a class of Human Immunodeficiency Virus protease inhibitors has gained importance in recent years due to its mode of action. QSAR analysis for multiple ligand-receptor complexes can be performed using binding interaction energies derived from the...

  • Coarse-grained versus atomistic simulations: realistic interaction free energies for real proteins. May, Ali; Pool, René; van Dijk, Erik; Bijlard, Jochem; Abeln, Sanne; Heringa, Jaap; Feenstra, K. Anton // Bioinformatics;Feb2014, Vol. 30 Issue 3, p326 

    Motivation: To assess whether two proteins will interact under physiological conditions, information on the interaction free energy is needed. Statistical learning techniques and docking methods for predicting protein–protein interactions cannot quantitatively estimate binding free...

  • Solvation pressure in chloroform. Hubel, H.; Faux, D. A.; Jones, R. B.; Dunstan, D. J. // Journal of Chemical Physics;5/28/2006, Vol. 124 Issue 20, p204506 

    Molecular dynamics (MD) simulations of chloroform vapor and liquid at normal temperature and pressure and liquid under hydrostatic pressure are presented, giving bond lengths and vibrational frequencies as functions of pressure. The change in bond lengths between vapor and liquid at normal...

  • Partial activation of α7 nicotinic acetylcholine receptors: insights from molecular dynamics simulations. Shi, Caijuan; Yu, Rilei; Shao, Shengjuan; Li, Yanni // Journal of Molecular Modeling;Feb2013, Vol. 19 Issue 2, p871 

    Nicotinic acetylcholine receptors (nAChRs) are drug targets for neuronal disorders and diseases. Partial agonists for nAChRs are currently being developed as drugs for the treatment of neurological diseases for their relative safety originated from reduced excessive stimulation. In the current...

  • Novel Quantitative Structure-Activity Studies of HIV-1 Protease Inhibitors of the Cyclic Urea Type Using Descriptors Derived from Molecular Dynamics and Molecular Orbital Calculations. Yoshida, Tatsusada; Fujita, Toshio; Chuman, Hiroshi // Current Computer-Aided Drug Design;Mar2009, Vol. 5 Issue 1, p38 

    Human immunodeficiency virus type 1 protease (HIV-1 PR) is an essential enzyme for the replication cycle of HIV-1. HIV-1 PR inhibitors have been extensively investigated as anti-AIDS drugs. For developments of HIV-1 PR inhibitors more promising than those utilized at the moment, the construction...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics